First Solar, Inc.
FSLR News Today: Stay Updated with the Latest First Solar, Inc. News in Real Time
Find FSLR news now at Meyka AI. Stay informed with the latest First Solar, Inc. stocks updates, including price news, market analysis, and expert insights.
April 06: Toronto Moves to Bar ICE at 2026 World Cup; Ottawa Silent
Toronto moves to bar ICE from the 2026 World Cup. Ottawa says ICE has no jurisdiction in Canada but offers few details. What this means for security, insurance, and investor risk.
US Restaurant Bankruptcies Spike: Gina Maria’s Closure – April 6
As pizza chain closes US locati cases rise, Gina Maria’s bankruptcy and Chapter 7 liquidation highlight restaurant closures 2026. What UK investors should watch now.
Mark Gibbens’ Top Tech Stocks to Watch: Palantir, Nvidia, & JPMorgan
Global tech stocks saw sharp swings in early 2026, with AI leaders correcting after a strong 2024-2025 rally. As of March 2026, valuations across major tech firms have cooled, creating fresh entry points for investors. Amid this shift, top CIO Mark Gibbens has highlighted a focused list of stocks that could benefit from the next…
April 06: Gen. Randy George Statement Deepens Pentagon Upheaval Risk
General randy george statement confirms a Pentagon leadership shake-up under Pete Hegseth, heightening defense-policy uncertainty and potential S&P 500 volatility for U.S. investors on April 06.
April 06: Stephen Miller’s Immigration Drive Puts Labor, CPI at Risk
Stephen Miller immigration agenda could tighten U.S. labor, lift food inflation, and sway CPI and Fed bets, posing near-term risks for S&P 500 investors.
April 6: Cuba Prisoner Release Signals US Tensions, Oil Supply Risk
Cuba prisoner release under US pressure signals policy shifts and Caribbean oil supply risk. What this means for Canadian fuel prices, shipping costs, and energy exposure.
Bitcoin USD Holds $69,500 as April CPI Data Shapes Next Move
Bitcoin USD trades at $69,507 with 3.9% gains. Technical analysis shows RSI at 41.28 and strong ADX trend. April 10 CPI data critical for direction.
Neurocrine Biosciences Close to $2.5B Acquisition of Soleno Therapeutics
We’re seeing a major move in biotech today. Neurocrine Biosciences is close to completing a deal to acquire Soleno Therapeutics in a transaction worth more than $2.5 billion, potentially rising to about $2.9 billion in cash. This deal is one of the most notable biotech acquisitions so far in 2026, and it aligns with Neurocrine’s growth strategy…
April 6: Mozzi’s ‘Demands’ Signal Reputation Risk for Banda, US Move
Edoardo Mapelli Mozzi demands and a possible Princess Beatrice US move raise governance and reputation risks for Banda’s property business. We assess implications for UK investors, fundraising, lender